manilatimes9h
Microbiotica unveils data on the mechanism of action of MB310, a clinical-stage drug candidate in development for the treatment of ulcerative colitis
MB310 has been developed as an oral capsule, dosed once daily, containing a defined consortium of eight live gut commensal ...
University of Arkansas15h
Innovative Insights in Metabolism Research: AIMRC Celebrates Another Impactful Year
Since the Arkansas Integrative Metabolic Research Center was established in 2021, supported researchers have secured over $34 million in external research funding and a majority of NIH funding on ...
WUFT18h
Trump's picks to oversee Medicare and biomedical research will divest stock
Dr. Mehmet Oz, nominated to run the Centers for Medicare & Medicaid Services, will sell shares in Eli Lilly and UnitedHealth.